Al-Nesf Maryam, Ibrahim Tayseer
Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar E-mail:
Qatar Med J. 2022 Mar 30;2022(2):1. doi: 10.5339/qmj.2022.fqac.1. eCollection 2022.
Allergic diseases are common medical conditions that now show an increasing trend globally and contributes to poor quality of life of the affected individual. Allergies can be fatal in a few instances such as anaphylaxis, severe asthma, and hereditary angioedema if the symptoms are not recognized and treated correctly. (1, 2) The first Allergy Conference in Qatar aimed to highlight the burden of allergic diseases in Qatar and globally with a special focus on educating both the physicians and the community. The preparation for this conference over the past three years threw up a few challenges, mainly owing to the coronavirus disease 2019 (COVID-19) pandemic that affected all forms of face-to-face interactions and social gatherings. Therefore, our conference was held virtually on February 05, 2022, which was more than two years from the first planned date. The conference was sponsored by the Hamad Medical Corporation in partnership with the Qatar Allergy and Immunology Society. In our scientific program, the scientific committees selected topics related to 3 major areas in allergy practice (systemic, respiratory, and skin allergy disorders). Abstract submissions were encouraged in areas related to audits, case reports, service development, and clinical and basic research in the field of allergy. Additional topics were included related to the current COVID-19 pandemic and COVID-19 vaccinations. We received 34 abstracts and accepted 28 for poster abstracts. Among them, 6 received approval for oral presentations; and 6 (21.4%) had the term COVID-19 or SARS-CoV-2 in their title, which supported the burden related to COVID-19 in our community and association between this new pandemic and our allergy practice and disorders.
过敏性疾病是常见的医学病症，目前在全球呈上升趋势，会影响患者的生活质量。在某些情况下，如过敏性反应、重度哮喘和遗传性血管性水肿，如果症状未得到正确识别和治疗，过敏可能会致命。（1, 2）卡塔尔的首届过敏会议旨在强调卡塔尔乃至全球过敏性疾病的负担，特别侧重于对医生和公众进行教育。过去三年筹备此次会议面临一些挑战，主要是由于2019冠状病毒病（COVID-19）大流行影响了所有形式的面对面互动和社交聚会。因此，我们的会议于2022年2月5日以线上形式举行，比最初计划的日期晚了两年多。该会议由哈马德医疗公司与卡塔尔过敏与免疫学会合作赞助。在我们的科学议程中，科学委员会选择了与过敏实践中3个主要领域（全身性、呼吸道和皮肤过敏疾病）相关的主题。鼓励提交与审核、病例报告、服务发展以及过敏领域的临床和基础研究相关领域的摘要。还纳入了与当前COVID-19大流行和COVID-19疫苗接种相关的其他主题。我们共收到34篇摘要，其中28篇被接受作为壁报摘要。其中，6篇获得口头报告批准；6篇（21.4%）标题中含有COVID-19或SARS-CoV-2，这证明了COVID-19对我们社区的影响以及这一新的大流行与我们的过敏实践和病症之间的关联。
